Eczema differential diagnosis: Difference between revisions
No edit summary |
|||
(10 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Eczema}} | {{Eczema}} | ||
{{CMG}}, {{AE}} | {{CMG}}, {{AE}} {{EdzelCo}} | ||
==Overview== | ==Overview== | ||
[[Eczema]] has various mimics with regards to the [[clinical presentation]], [[severity]], and [[course of disease]]. A strong [[clinical evaluation]] by the [[physician]] based on the presenting [[signs]] and [[symptoms]] is needed to come up with the correct diagnosis. [[Differential diagnoses]] of [[eczema]] include [[infectious disease]], [[inflammatory disease]], [[immunodeficiency problem]], or a [[nutritional deficiency]].<ref name="pmid31563186">{{cite journal| author=Raveendran R| title=Tips and Tricks for Controlling Eczema. | journal=Immunol Allergy Clin North Am | year= 2019 | volume= 39 | issue= 4 | pages= 521-533 | pmid=31563186 | doi=10.1016/j.iac.2019.07.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31563186 }} </ref> | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
A strong [[clinical evaluation]] by the [[physician]] based on the presenting [[signs]] and [[symptoms]] is needed to come up with the correct diagnosis. | |||
*Table 1 summarizes these [[medical conditions]], with their corresponding expected time of | *Table 1 summarizes these [[medical conditions]] that can mimic the presentation of [[eczema]], with their corresponding expected time of onset. | ||
{| style="border: 0px; font-size: 90%; margin: 1px; width: " align="center" 1000px;" | {| style="border: 0px; font-size: 90%; margin: 1px; width: " align="center" 1000px;" | ||
| valign="top" | | | valign="top" | | ||
|+<big>''' Table 1. [[Differential Diagnosis]] of [[Eczema]].'''</big> | |+<big>''' Table 1. [[Differential Diagnosis]] of [[Eczema]].'''</big><ref name="pmid31563186">{{cite journal| author=Raveendran R| title=Tips and Tricks for Controlling Eczema. | journal=Immunol Allergy Clin North Am | year= 2019 | volume= 39 | issue= 4 | pages= 521-533 | pmid=31563186 | doi=10.1016/j.iac.2019.07.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31563186 }} </ref> | ||
! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Type}} | ! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Type}} | ||
! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Medical Condition}} | ! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Medical Condition}} | ||
Line 30: | Line 29: | ||
| style="padding: 2px 2px; background: #F5F5F5;" | | | style="padding: 2px 2px; background: #F5F5F5;" | | ||
*[[Morbiliform rash]] | *[[Morbiliform rash]] | ||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]] | | style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]. | ||
|- | |- | ||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Contact Dermatitis] | | align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Contact Dermatitis]] | ||
| style="padding: 2px 2px; background: #F5F5F5;" | | | style="padding: 2px 2px; background: #F5F5F5;" | | ||
*[[Vesicular]] and [[pruritic]]. | *[[Vesicular]] and [[pruritic]]. | ||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]] | | style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]. | ||
|- | |- | ||
| rowspan="1" align="center" style="padding: 2px 2px; background: #E6E6FA; font-weight: bold" |[[Neoplastic]] | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Cutaneous T-cell Lymphoma]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Eczematous]] [[patch]]. | |||
*[[Resistant]] to [[topical steroids]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Adulthood]]. | |||
|- | |||
| rowspan="4" align="center" style="padding: 2px 2px; background: #E6E6FA; font-weight: bold" |[[Immunodeficiency]] | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Wiskott-Aldrich Syndrome]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]. | |||
|- | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Netherton syndrome]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]. | |||
|- | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Hyper IgE syndrome]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]. | |||
|- | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[DOCK8]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]. | |||
|- | |||
| rowspan="2" align="center" style="padding: 2px 2px; background: #E6E6FA; font-weight: bold" |[[Nutritional Deficiency]] | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Zinc]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Weight loss]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]] to [[early childhood]]. | |||
|- | |||
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Biotin]] | |||
| style="padding: 2px 2px; background: #F5F5F5;" | | |||
*[[Failure to thrive]]. | |||
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]] to [[early childhood]]. | |||
|- | |||
|} | |} | ||
Line 45: | Line 85: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[ | [[category:Up to Date]] |
Latest revision as of 07:43, 13 November 2023
Eczema Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Eczema On the Web |
American Roentgen Ray Society Images of Eczema |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]
Overview
Eczema has various mimics with regards to the clinical presentation, severity, and course of disease. A strong clinical evaluation by the physician based on the presenting signs and symptoms is needed to come up with the correct diagnosis. Differential diagnoses of eczema include infectious disease, inflammatory disease, immunodeficiency problem, or a nutritional deficiency.[1]
Differential Diagnosis
A strong clinical evaluation by the physician based on the presenting signs and symptoms is needed to come up with the correct diagnosis.
- Table 1 summarizes these medical conditions that can mimic the presentation of eczema, with their corresponding expected time of onset.
Type | Medical Condition | Manifestations | Expected Time of Presentation |
---|---|---|---|
Inflammatory | Psoriasis |
|
Adolescence to adulthood. |
Viral Exanthem | Infancy. | ||
Contact Dermatitis | Infancy. | ||
Neoplastic | Cutaneous T-cell Lymphoma | Adulthood. | |
Immunodeficiency | Wiskott-Aldrich Syndrome |
|
Infancy. |
Netherton syndrome |
|
Infancy. | |
Hyper IgE syndrome |
|
Infancy. | |
DOCK8 |
|
Infancy. | |
Nutritional Deficiency | Zinc | Infancy to early childhood. | |
Biotin | Infancy to early childhood. |
References
- ↑ 1.0 1.1 Raveendran R (2019). "Tips and Tricks for Controlling Eczema". Immunol Allergy Clin North Am. 39 (4): 521–533. doi:10.1016/j.iac.2019.07.006. PMID 31563186.